Insider Deck research · Earnings

BBIO earnings · BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. (BBIO) earnings history, EPS vs consensus, beat rate, forward estimates, and transcripts on Insider Deck. Latest print Q1 '26: EPS $-0.84 vs consensus $-0.62. Beat rate 25% across 4 prints. Next listed date 2026-08-10.

Latest EPS-$0.84-0.4% surprise

Beat rate25%4 prints

Avg surprise-0.3%vs consensus

Next printAug 10, 2026EPS -$0.58

Quarterly EPS vs consensus

4 quarters

Actual ConsensusLabels: beat $ · YoY %Revisions 7 up / 4 down

Earnings transcripts

Read management commentary and analyst Q&A.

No transcript dates are available yet for this ticker.

Forward estimates

Consensus expectations and estimate momentum.

PeriodEPSRevenueGrowth

0QJun 2026

-$0.58$219.7M+38.7%

+1QSep 2026

-$0.49$251.8M+31.5%

0YDec 2026

-$2.19$960.7M+42.2%

+1YDec 2027

$0.58$1.6B+126.5%

Primary research

Recent company filings

Jump directly to earnings releases, quarterly reports, and material updates.

Frequently asked questions

When is the next BBIO earnings date?

The next listed earnings date for BBIO is 2026-08-10. Dates can move — confirm on the earnings desk.

What is BBIO's earnings beat rate?

BBIO has beaten consensus on roughly 25% of recent prints in the Insider Deck sample.

Where are BBIO earnings call transcripts?

Ready transcripts appear under BBIO earnings as /stocks/us/bbio/earnings/{year}/q{n}.

Where can I research BBIO on Insider Deck?

BridgeBio Pharma, Inc. (BBIO) research covers KPIs, earnings, fundamentals, institutional ownership, 13F flow, news, and DCF valuation.